Rheumatoid arthritis (RA)
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disease primarily affecting synovial joints and leading to a progressive destruction of the cartilage and bone. A combination of genetic predisposition, immunological deregulation, and environmental factors contribute to its pathogenesis [1] . The most recognized environmental risk factor for the development and severity of RA is cigarette smoking [2] [3] [4] . RA synovium is characterized by synovial hyperplasia and infiltration of inflammatory cells together with high production of proinflammatory cytokines such as tumor necrosis alpha (TNFα) [5] . Thus, inhibition of inflammatory processes is the main strategy in the treatment of RA.
SIRTs are class III histone deacetylases that regulate the activity of histones and nonhistone proteins by posttranslational modifications [6] . Initially, SIRTs were identified as regulators of cell metabolism, survival, aging, and Electronic supplementary material The online version of this article (doi:10.1007/s00109-015-1332-9) contains supplementary material, which is available to authorized users.
inflammation [7] . Recent studies demonstrated that SIRTs are involved in the regulation of signaling pathways induced by environmental stress factors, such as cigarette smoking. Exposure to cigarette smoke reduced the expression of SIRT1 in human and rat lungs as well as in human endothelial, epithelial, and monocyte-macrophage cell lines [8] [9] [10] .
The role of SIRT1 in cancer and inflammation, in particular arthritis, is controversial. Expression of SIRT1 was shown to be increased in the synovium of RA patients [11] . Downregulation of SIRT1 or inhibition of sirtuin activities in synovial cells of RA patients was found to reduce the expression of inflammatory mediators [11, 12] , and overexpression of SIRT1 increased production of pro-inflammatory cytokines in rheumatoid arthritis synovial fibroblasts (RASF) and monocytes from healthy persons [11] . In contrast, levels of SIRT1 were diminished in joint tissues of mice with collagen-induced arthritis [13] . Moreover, deletion of SIRT1 aggravated inflammatory arthritis in serum transfer arthritis model and increased production of pro-inflammatory cytokines in macrophages [14] .
In the current study, we further analyzed the role of SIRT1 in RA. To elucidate the function of SIRT1 in RA synovium, we used a next generation sequencing approach to identify specific targets and biological processes regulated by SIRT1 in RASF.
Material and methods

Patient samples and cell culture
Synovial tissues were obtained from RA patients undergoing joint replacement surgery at the Schulthess Clinic Zurich after obtaining informed written consent according to the principles of the 1964 Declaration of Helsinki. For experiments with human tissues, ethical approval was obtained at the Swiss Ethical commission. RA patients fulfilled the American College of Rheumatology criteria for the classification of RA [15] . RASF were isolated and cultured as described previously [16] . Cells between passages 4 to 8 were used.
CSE preparation and stimulation assays
Cigarette smoke extract (CSE) was prepared using a modification of the method described by Vassallo et al. [17] . CSE of 100 % was prepared by bubbling of the smoke of one cigarette into 10 ml of cell culture medium at a rate of one cigarette per 7 min. CSE was sterile filtered through 0.2-μm filter and diluted to 5 % CSE with cell culture medium. The pH of 5 % CSE and of the control cell culture medium was equal and remained unaltered during the cultivation. The cigarettes used contained 10 mg tar, 0.8 mg nicotine, and 10 mg carbon monoxide (Marlboro Red). RASF were stimulated with 5 % CSE or 10 ng/ml TNFα (R&D systems) for 24 h.
Overexpression and gene silencing
RASF were transfected using the Basic Nucleofector Kit for Primary Mammalian Fibroblasts (Amaxa) according to the manufacturer's instructions. In silencing experiments, 100 μM of validated siRNA for SIRT1 or control siRNA (Invitrogen) was used. For overexpression of SIRT1, 1 μg of SIRT1 wild-type or empty pcDNA3.1(−) (mock) expression vectors were used as previously described [11] . Silencing and overexpression of SIRT1 were verified by Western blot analysis or real-time PCR (Supplementary Fig. 1 ).
RNA isolation and quantitative real-time PCR
RNA was isolated, reverse transcribed, and gene expression quantified as previously described [18] . Hypoxanthine phosphoribosyltransferase 1 (HPRT1) was used as an endogenous control. The primer sequences used are given in the Supplementary Table S1 .
Next generation sequencing and functional annotation analysis
For transcriptome analysis, the expression of SIRT1 was downregulated or upregulated in RASF (n=2) for 72 h as described above. RNA was isolated using RNeasy Plus Micro Kit (Qiagen) followed by treatment with RNase-free DNase (Invitrogen). RNA was cleaned-up using RNeasy Mini Kit (Qiagen). The library constructs were produced using TruSeq Stranded mRNA Sample Preparation Kit according to Illumina TruSeq® Stranded mRNA protocol. Libraries were pooled and further used for cluster generation using TruSeq SR Cluster Kit v3-cBot-HS reagents and sequenced with TruSeq SBS Kit v3-HS reagents on Illumina HiSeq 2500 in the high output mode. For pathway enrichment analysis, only coding transcripts that were found to be altered by silencing as well as by overexpression of SIRT1 (cutoff log2 ratio >±0.4) and had a signal intensity of >10 were taken into account. Functional annotation clustering was done using the Database for Annotation, Visualization and Integrated Discover (DAVID) [19, 20] . Gene Ontology (GO) terms corresponding to the biological processes (BP-FAT) were used to group the genes. The significance of the gene-term enrichment was determined by Fischer's exact test, and p values ≤0.05 were considered strongly enriched.
Proliferation and adhesion assays
Proliferation and adhesion of RASF were measured in the xCELLigence Real-Time Cell Analyzer (RTCA) DP system (Bucher Biotec AG). For proliferation assay, RASF were transfected with SIRT1 siRNA or control siRNA as described above, and 2500 cells were seeded in each well. Medium was changed 24 h after transfection. The rate of proliferation was determined by calculating the slope of the cell index (CI) curve in the interval between 40 and 85 h after transfection, since the best efficacy of SIRT1 silencing was observed 48-96 h after transfection. To investigate the effect of SIRT1 on adhesion, RASF were transfected for 72 h with SIRT1 siRNA or control siRNA as described above. Cells were detached with accutase, and 2500 cells were seeded in each well. The rate of adhesion was determined by calculating the slope of the CI curve between 0 and 60 min after seeding of cells.
Leukocyte adhesion assay
Leukocyte adhesion to RASF was performed based on the protocol by Tessier et al. [21] . Peripheral blood mononuclear cells (PBMCs) were isolated from whole EDTA blood from one healthy donor by Ficoll paque plus (GE Healthcare). RASF were transfected with SIRT1 or scrambled siRNA for 72 h before 1× 10 6 PBMCs were added to 3×10 4 RASF for 1 h. The wells were washed 3 times with PBS, and the adherent cells were stained with 0.01 % methylene blue, 0.05 % crystal violet, 2 % methanol, 3 % acetic acid, and 95 % distilled H 2 O. PBMCs were counted in 4 visual fields (×100 magnification) per condition.
Immunohistochemistry
Formalin-fixed, paraffin-embedded synovial tissues (n=23) were deparaffinized and pretreated with 10 mM citrate buffer (pH=6) for antigen unmasking. After washing with ddH 2 O, blocking of endogenous peroxidase activity (3 % H 2 O 2 ) and of nonspecific binding (5 % goat serum in antibody diluent (Dako)), slides were incubated with rabbit IgG (Jackson ImmunoResearch) or rabbit anti-SIRT1 antibody (E104, Abcam, #ab32441, 1:40 in antibody diluent). After washing, the slides were incubated with biotinylated goat-anti-rabbit antibodies (Jackson ImmunoResearch, 1:500 in antibody diluent/5 % human serum) and the Dako EnVision+ System-for horseradish peroxidase (HRP). SIRT1-positive cells were visualized using 3.3'-diaminobenzidin (DAB). Nuclei were counterstained with hematoxylin. The intensity of the SIRT1 staining in synovial tissues was evaluated by two independent observers, using a gradual scoring scale from 0 (no staining) to 4 (strong staining). For the assessment of synovitis in synovial tissues, thickness of lining cell layer, cellular density of synovial stroma, and leukocytic infiltrate were semiquantitatively evaluated in hematoxilin/eosin-stained tissues as described by Krenn et al. [22] . Patient's characteristics are shown in Table 1 . In slides stained for SIRT1, stromal characteristics could not be evaluated, and thus, the synovitis score comprised thickness of lining layer and infiltration only.
Immunoblotting
Whole cell lysates were prepared by lysing the cells in Laemmli buffer. Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked with 5 % milk in TBS-T and incubated overnight at 4°C with mouse anti-proliferating cell nuclear antigen (PCNA) (PC10, Novus Biologicals #NB500-106, 1:1000), mouse anti-tubulin (DM1A, Abcam, # ab7291, 1:10,000), rabbit anti-SIRT1 (E104, Abcam, #ab32441, 1:500), or mouse anti-Vimentin antibodies (Abcam, #ab7752, 1:1000) in 5 % milk. HRPlabeled species-specific secondary antibodies (Jackson ImmunoResearch, 1:10,000) and enhanced chemiluminescence (GE Healthcare) were used for visualization.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 software. Values are presented as mean±SEM. Data were analyzed using t test or Wilcoxon signed rank test as indicated. Correlation of SIRT1 expression with levels of synovitis or infiltration was investigated using Spearman correlation. P values <0.05 were considered significant.
Results
Regulation of SIRT1 expression in RASF and synovial tissues
Smoking and TNFα are critical factors in the pathogenesis of RA. To investigate the regulation of SIRT1 in RASF, we stimulated the cells with 5 % CSE or 10 ng/ml TNFα for 24 h. Western blot analysis revealed decreased protein levels of SIRT1 in RASF stimulated with CSE (Fig. 1a) . Opposite to CSE, stimulation of RASF with TNFα increased protein expression of SIRT1 (Fig. 1a) . Costimulation with CSE and TNFα together increased the protein levels of SIRT1 indicating that upregulation of SIRT1 by TNFα is dominant over downregulation of SIRT1 after CSE (Fig. 1c) . To analyze the effect of smoking on SIRT1 expression in vivo, we compared the expression of SIRT1 in synovial tissue sections from RA smokers with RA nonsmokers by immunohistochemistry. Scoring of SIRT1 staining intensities revealed increased expression of SIRT1 in synovial tissues of RA smokers when compared to RA nonsmokers (Fig. 1c, d ).
When expression of SIRT1 in synovial tissues was compared to the degree of synovitis, a positive correlation (p=0.008) was observed (Fig. 2a) . By separately analyzing the two components of the synovitis score, namely, leukocytic infiltration and thickening of the synovial lining layer, a significant positive correlation between the expression of SIRT1 and leukocytic infiltration was seen (p=0.01), while no correlation was found between SIRT1 levels and synovial thickening (Fig. 2a) . Assessment of synovitis in smoking and nonsmoking RA patients showed that smoking RA patients had significantly higher synovitis score and more inflammatory cells infiltrating the synovial tissue compared to nonsmoking RA patients. Moreover, the density of synovial stroma was increased in smoking RA patients (Fig. 2b) .
Targets and biological processes regulated by SIRT1 in RASF
To investigate the effect of increased SIRT1 expression in RA synovial tissues and RASF, as shown previously by Niederer et al. [11] , and the particular high levels of SIRT1 in RA smokers observed in this study, a next generation sequencing approach was applied. The expression of SIRT1 was decreased by SIRT1 silencing or increased by SIRT1 overexpression, and changes in gene expression were measured by poly-A-enriched transcriptome sequencing. Forty-six genes were upregulated by SIRT1 overexpression and downregulated by SIRT1 silencing, whereas 52 genes were downregulated after SIRT1 overexpression and upregulated in SIRT1 silenced RASF (Fig. 3, Supplementary Table S2 ). To identify the biological processes affected, we grouped the genes into specific biological processes using the GO annotation program DAVID. After grouping the genes that were upregulated by SIRT1 overexpression and downregulated by SIRT1 silencing, we found that the top 5 biological processes with the highest numbers of enriched genes are Bresponse to organic substance,^Bdefense response,^Bcell adhesion, Bbiological adhesion,^and Binflammatory response( Supplementary Table S3 ). Grouping of genes that were downregulated by SIRT1 overexpression and upregulated by SIRT1 silencing revealed that the top 3 enriched biological processes are Bresponse to wounding,^Bdefense response,^and Binflammatory response^(Supplementary Fig. 1 Expression of SIRT1. a Stimulation of RASF (n=6) with 5 % CSE for 24 h decreases the protein levels of SIRT1, but stimulation of RASF (n=10) with 10 ng/ml TNFα for 24 h increased the protein levels of SIRT1. b Costimulation of RASF with CSE and TNFα together increased the protein levels of SIRT1 in control transfected RASF. c Scoring of SIRT1 staining intensities in synovial tissues of RA nonsmokers (n=11) and RA smokers (n=12) shows increased SIRT1 levels in the synovium of RA smokers. d Representative sections of RA synovial tissues showing higher expression of SIRT1 (brown) in RA smokers as compared to RA nonsmokers. Insets show the control IgG staining. Nuclei were counterstained with hematoxylin (blue). Original magnification: ×100 (top) and×400 (bottom); scale bar=100μm Table S4 ). Taken together, modifications of SIRT1 levels induced strongest changes in the expression of genes involved in the regulation of inflammation and cell adhesion.
Verification of SIRT1 targets that might play an important role in the pathogenesis of RA in more patients confirmed increased expression of cadherin 4 (CDH4) by silencing of SIRT1 (Fig. 4a) , whereas levels of chemokine (C-X3-C motif) Fig. 2 Synovitis score. a Enhanced expression of SIRT1 correlates with increased synovitis score and leukocytic infiltration in RA synovial tissues. b Synovial tissues of RA smokers show higher synovitis score and leukocytic infiltration than the synovial tissues of RA non smokers. *p<0.05 as measured by t test Fig. 3 Modification of SIRT1 levels induces global changes in the gene expression in RASF. Levels of SIRT1 were decreased by SIRT1 silencing or increased by transfection with SIRT1 specific vector in RASF (n=2). Changes in the global gene expression were measured by poly-Aenriched transcriptome sequencing. a Genes that were downregulated after overexpression of SIRT1 and upregulated after silencing of SIRT1. b Genes that were upregulated by SIRT1 overexpression and downregulated by silencing of SIRT1 ligand 1 (CX3CL1) and of JunB proto-oncogene (JunB) were significantly upregulated by overexpression of SIRT1 (Fig. 4b, c) .
Effect of SIRT1 on adhesion and proliferation of RASF
Even though not reaching statistical significance (p=0.054), adhesion was found to be one of the top enriched biological processes in the functional annotation analysis of SIRT1 target genes. Therefore, we investigated the effects of SIRT1 silencing on the regulation of cell adhesion. Expression of SIRT1 in RASF was reduced by silencing of SIRT1 with siRNA, and cell behavior was monitored using the xCELLigence RTCA system. Strongest changes in adhesion of RASF were detected in the first 60 min after seeding. Therefore, the slope of the curve between 0 and 60 min was calculated and used as a parameter for changes in cell adhesion. While in 3 out of 5 patients, adhesion was stronger in SIRT1 siRNA than control siRNA transfected cells, in two patients, this effect of SIRT1 silencing on adhesion was not seen (Fig. 5a, b) . Taking all patients together, no significance was reached (Fig. 5c) .
The chemokine CX3CL1 and the receptor stabilin-2 (STAB2) were listed in the adhesion pathways as well as in inflammatory pathways (Bdefense response^and Bregulation of inflammatory response^). Both of these genes were implicated in the adhesion of leukocytes to endothelial cells [23, 24] . Therefore, we incubated PBMCs with RASF that were silenced for SIRT1 and control transfected RASF, respectively, for 1 h. After washing, significantly less PBMCs were attached to SIRT1 silenced RASF than to the control transfected RASF (Fig. 5d) .
SIRT1 was also shown to regulate cell proliferation [25] [26] [27] [28] [29] [30] . Altered proliferation of synovial cells was suggested to contribute to the synovial hyperplasia in RA [31] . To study the effect of SIRT1 on proliferation, RASF were seeded immediately after transfection with SIRT1 siRNA, and the cell behavior was monitored in real-time over a period of 160 h using the xCELLigence RTCA system. Proliferation rate of RASF transfected with SIRT1 siRNA was significantly lower than in control transfected cells 40-85 h after transfection (Fig. 6b) . After around a week of growth, the cell index reached the same index in SIRT1 silenced RASF as in control transfected cells indicating that SIRT1 silencing specifically affected proliferation and not the apoptosis where the cell index would constantly decrease over time (Fig. 6a ). To confirm an effect of SIRT1 on proliferation, we measured levels of PCNA 72 h after silencing of SIRT1. PCNA levels were significantly lower in SIRT1 siRNA transfected cells compared to control transfected RASF (Fig. 6c) .
Discussion
In the current study, we investigated the regulation and function of SIRT1 in RA synovium. We found that expression of SIRT1 in vitro is differentially regulated by TNFα and CSE exposure in RASF. Expression of SIRT1 protein in vitro was downregulated by stimulation of RASF with CSE, whereas treatment with TNFα increased protein levels of SIRT1. At the mRNA level, we previously found that the expression of SIRT1 transcript is not affected by stimulation with CSE [32] whereas TNFα stimulation upregulated the levels of SIRT1 mRNA [11] . We studied the regulation of SIRT1 protein in vivo and found that SIRT1 levels were upregulated in the synovial tissues of RA smokers and correlated positively with increased leukocytic infiltration. Previously, it was shown that smokers respond less to therapies with disease modifying antirheumatic drugs and had higher levels of the chemokine MIP-1α [33] . The same study showed that CSE induces chemotaxis in vitro. Thus, smoking could enhance leukocytic infiltration in synovial tissues. This can lead to higher levels of TNFα, which upregulates the expression of SIRT1 in the joints of RA smokers. Indeed, smoking was shown to increase the levels of TNFα in the serum [34] . Moreover, release of TNFα by stimulated T lymphocytes was significantly higher in RA patients who smoked than in those who never smoked Fig. 4 Modification of SIRT1 levels induces changes in the gene expression in RASF. Levels of SIRT1 were decreased by SIRT1 silencing or increased by transfection with SIRT1 specific vector in RASF (n = 4-10). Silencing of SIRT1 significantly increased the expression of CDH4 (a) whereas overexpression of SIRT1 enhanced the levels of CX3CL1 (b) and JunB (c). *p<0.04 as determined by Wilcoxon signed rank test [35] . These results are in line with clinical studies showing that RA smokers show a poor response to anti-TNF treatment and RA heavy smokers have the poorest drug survival [36] . At the cellular level, exposure to cigarette smoke was also shown to increase the production of TNFα in inflammatory cells in vitro [37] [38] [39] . However, as reported previously, we could not detect TNFα expression in unstimulated or CSE-treated RASF [32] . Since cigarette smoke does not induce TNFα in RASF, the expression of SIRT1 in RASF in vitro is regulated by CSE only, whereas in vivo increased levels of TNFα in the synovium of RA patients could overlap the effect of smoking resulting in upregulation of SIRT1 levels. Accordingly, levels of SIRT1 were increased in RASF stimulated with TNFα and CSE in combination, which points to a stronger effect of TNFα than CSE in the regulation of SIRT1.
SIRT1 is a multifunctional protein that regulates a variety of cellular processes including cell survival, metabolism, aging, inflammation, and cancerogenesis in different cell types and tissues [7, 40] . To investigate the target genes and biological processes regulated by SIRT1 in RASF, we silenced or overexpressed SIRT1 and found that modifications of SIRT1 levels induce changes in the expression of genes involved in the regulation of inflammation and cell adhesion. The function of SIRT1 in inflammation is controversial. SIRT1 was shown to regulate many anti-inflammatory processes, but also some pro-inflammatory pathways [41, 42] . The anti-inflammatory effect of SIRT1 and also of SIRT6, which we previously found to be induced by smoking, was shown to be mediated by inhibition of NF-kB-dependent gene expression in other cell types [32, 43, 44] . In RASF, however, we and others could show that SIRT6 does not affect the expression of the NF-kBdependent pro-inflammatory cytokines IL-6 or IL-8, but reduces expression of MMP1 via direct deacetylation of the MMP1 promoter [32, 45] . SIRT1 on the other hand was reported to promote the production of these pro-inflammatory cytokines in RASF and human monocytes [11] . Our results confirm the pro-inflammatory role of SIRT1 in RASF, suggesting that neither SIRT6 nor SIRT1 negatively regulate NFkB in RASF. A possible regulatory pathway in RASF might be the regulation of AP-1, since we found that SIRT1 enhances the expression of JunB, a component of the AP-1 Fig. 5 Effect of SIRT1 silencing of rate of adhesion in RASF. The expression of SIRT1 was downregulated by transfection of RASF with SIRT1 specific siRNA for 72 h. Cells were seeded in E-plates, and the rate of adhesion was determined by analyzing the slope of the curves in the first 60 minu after seeding of the cells in real-time using the xCELLigence RTCA system. a Silencing of SIRT1 (black line) altered the rate of adhesion in 3 patients as compared to control transfected cells (gray line), whereas no effect of SIRT1 silencing on adhesion was observed in 2 patients (b). Taking all patients together, no significant changes in the rate of adhesion upon SIRT1 silencing were detected (c). d Significantly less PBMCs attached to SIRT1 silenced RASF compared to control transfected RASF after 1 h of coincubation. Representative pictures of 1 out of 6 experiments are shown. *p<0.04 as determined by Wilcoxon signed rank test transcription factor complex, which was shown to regulate RA-associated inflammation [46] .
We also investigated the role of SIRT1 in the regulation of cell adhesion. Despite effects of SIRT1 on the expression of genes involved in the regulation of adhesion (CDH4, CDH1), we could not detect a consistent effect of SIRT1 silencing on adhesion of RASF to the cell culture dish surface in functional assays. The variability in the adhesion of RASF in response to SIRT1 silencing could be triggered by differences in the genetic background of the patients or the heterogeneity of RA. Contrasting effects of SIRT1 were already reported in the regulation of cancer cells. The dual role of SIRT1 in promoting or suppressing tumor progression was suggested to correlate with the genetic background of the tumor cells and with the presence or absence of p53 [47, 48] . Interestingly, p53 was shown to be overexpressed in RA synovium and to contribute to the regulation of synoviocyte invasiveness, apoptosis, and proliferation [49] [50] [51] . Somatic mutations in the p53 gene were detected in RA synovium and were functionally linked to the regulation of inflammation [52, 53] . Thus, depending on the expression of wild type or mutated form of p53 in RA patients, the effect of SIRT1 in RASF could be more or less prominent. Furthermore, the transcription factor p53 was reported to control the transcription of CX3CL1 [54] . Therefore, SIRT1-dependent changes of CX3CL1 in RASF might be mediated via p53.
CX3CL1 and STAB2, which were both upregulated by SIRT1, were previously described to increase adhesion of leukocytes to endothelial cells [23, 24] . Their downregulation might also be responsible for the decreased adhesion of leukocytes to SIRT1 silenced RASF.
Previously, we could show that SIRT1 induces apoptosis in RASF [11] . Here, we found that in addition, silencing of Fig. 6 Silencing of SIRT1 decreases rate of proliferation in RASF. For silencing of SIRT1, RASF were transfected with SIRT1 siRNA (black line) or control siRNA (gray line) and seeded directly in E-plates. The graphs show dynamics and rate of proliferation in RASF in one representative experiment (a). The rate of proliferation was monitored in real-time using the xCELLigence RTCA system and was determined by analyzing of the slope of the curves between 40 and 85 h (n=5) (b). PCNA levels were measured after 72 h of transfection with siRNA against SIRT1 or scrambled control (n=7) (c). **p<0.01, ***p<0.001 as measured by t test SIRT1 reduced the proliferation rate of RASF. Similarly, decreased proliferation upon silencing of SIRT1 was reported in human malignant glioma cells, melanoma cells, vascular smooth muscle cells, and murine osteoprogenitors [25] [26] [27] [28] . However, SIRT1 was also shown to inhibit proliferation in human colon cancer cells and murine gut epithelial cells [29, 30] . Since CX3CL1 was previously reported to increase the proliferation of endothelial cells [55] and we found that CX3CL1 levels are reduced by SIRT1 silencing, it is feasible to assume that SIRT1 silencing decreases proliferation of RASF via reduction of CX3CL1 levels.
In summary, our data showing that SIRT1 contributes to the activation of human synovial cells by promoting the proinflammatory, proliferative and potentially adhesive properties of RASF suggest an adverse function of SIRT1 in the pathogenesis of RA and are in line with previous reports in human cells [11, 12] . In mice, however, SIRT1 was shown to have the opposite effects, since deletion of SIRT1 aggravated the inflammatory arthritis in serum transfer arthritis model and increased production of pro-inflammatory cytokines in murine macrophages [14] . Whether these different effects of SIRT1 could be species or cell type specific needs to be further elucidated. Thus, it is important to reconsider the influence of substances that modify SIRT1 activity in all cell types prior their application in murine models or clinical trials.
